Bowel (colorectal) cancer, Breast cancer, Cervical cancer, Head and neck cancers, Kidney cancer, Lung cancer, Non small cell lung cancer (NSCLC), Oesophageal cancer, Ovarian cancer, Pancreatic cancer, Renal cell cancer, Secondary cancers
Open
Phase 1/2
This trial is looking at a drug called UCB4594 by itself and in combination with other treatments for solid cancers that have spread (advanced cancer).
It is open to people whose treatment has stopped working and there is no standard treatment available.
Recruitment start: 9 July 2024
Recruitment end: 28 February 2029
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Fiona Thistlewaite
Cancer Research UK
Centre for Drug Development
UCB Biopharma SRL
This is Cancer Research UK trial number CRUKD/24/001.
Last reviewed: 20 March 2025
CRUK internal database number: 19883